Reduced Expression of Collagen Type I and Increased Expression of Matrix Metalloproteinases 1 in Patients With Crohn's Disease

REFERENCES

• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol. 2000; 120: 241–246, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kjeldsen J, Schaffalitzky de Muckadell O B, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut. 1995; 37: 805–810, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Regan M C, Flavin B M, Fitzpatrick J M, O'Connell P R. Stricture formation in Crohn's disease: The role of intestinal fibroblasts. Ann Surg. 2000; 231: 46–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Henkel W, Glanville R W. Covalent crosslinking between molecules of type I and III collagen. Eur J Biochem. 1982; 122: 205, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Fleischmajer R, Perlish J S, Burgeson R E, Shaikh-Bahai F, Timpl R. Type I and type III interactions during fibrillogenesis. Ann NY Acad Sci. 1990; 580: 161, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bailey C J, Hembry R M, Alexander A, Irving M H, Grant M E, Shuttleworth C A. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol. 1994; 47: 113–116, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Welgus H G, Jeffrey J J, Eisen A Z. The collagen substrate specificity of human skin fibroblast collagenases. J Biol Chem. 1981; 256: 9511, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sommerville R P, Oblander S A, Apte S S. Matrix metalloproteinases: Old dogs with new tricks. Genome Biol. 2003; 4: 216–222, [CROSSREF]
   Google Scholar
• Vaalamo M, Mattila L, Johansson N, Kariniemi A L, Karjalainen-Lindsberg M L, Kähäri V M, Saarialho-Kere U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997; 109: 96, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Selby W. Pathogenesis and therapeutic aspects of Crohn's disease. Vet Microbiol. 2000; 77: 505–511, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Okabe N. The pathogenesis of Crohn's disease. Digestion. 2001; 63: 52–59, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Brignola C, Belloli C, Ardizzone S, Astegiano M, Cottone M, Trallori G. The relationship between heritability and smoking habits in Crohn's disease. Italian Cooperative Study Group. Am J Gastroenterol. 2000; 95: 3171–3175, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Jorgensen L N, Kallehave F, Christensen E, Siana J E, Gottrup F. Less collagen production in smokers. Br J Surg. 1998; 123: 450–455
   Google Scholar
• Alexander A C, Irving M H. Accumulation and pepsin solubility of collagens in the bowel of patients with Crohn's disease. Dis Colon Rectum. 1990; 33: 956–962, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stallmach A, Schuppan D, Riese H H, Metthes H, Riecken E O. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology. 1992; 102: 1920–1929, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Klinge U, Si Z Y, Zheng H, Schumpelick V, Bhardwaj R S, Klosterhalfen B. Abnormal collagen I and III distribution in the skin of patients with incisional hernia. Eur Surg Res. 2000; 32: 43–47, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ravanti L, Kähäri V M. Matrix metalloproteinases in wound repair. Int J Mol Med. 2000; 6: 391–407, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Woessner J F. The family of matrix metalloproteinase. Ann NY Acad Sci. 1994; 732: 11–21, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Parsons S L, Watson S A, Brown P D, Collins H M, Steele R JC. Matrix metalloproteinases. Br J Surg. 1997; 84: 160–166, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Baragawanath P, Hopkins I, Evans D, Jasani B, Harding K, Mansel R. Chronic human wounds are associated with elevated tissue levels of MMP-9 (92 kDa gelatinase). Br J Surg. 1996; 83: 684–685
   Google Scholar
• Von Lampe B, Barthel B, Coupland S E, Riecken E O, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut. 2000; 47: 63–73, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McKaig B C, McWilliams D, Watson S A, Mahida Y R. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol. 2003; 162: 1355–1360, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar